Altius Institute For Biomedical Sciences

Seattle, WA

UEI
MVEEWMEJJB24
CAGE
7HKF4
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
2211 Elliott Ave #600, Seattle, WA 98121, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract vehicles

No active vehicles.

1 expired vehicle

Grant awards

Award Agency Obligated Awarded
Discriminating between causes of age-related variegated gene expression R00AG061216 National Institute on Aging (NIH) $2,176,254
Elucidation of the organizing principles of the regulatory genome through large-scale data integration R35HG011317 National Human Genome Research Institute (NIH) $3,327,780
Encode mapping center-a comprehensive catalog of dnase i hypersensitive sites UM1HG009444 National Human Genome Research Institute (NIH) $22,096,741
Center for photogenomics RM1HG007743 National Human Genome Research Institute (NIH) $10,061,117
High-resolution mapping of dnasei hypersensitive regulatory DNA in gtex samples U01HG007599 National Human Genome Research Institute (NIH) $2,470,815

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Dana-Farber Cancer Institute, Inc. Dr. Gimelbrant will oversee multi-deep sequencing, and related probe design for target capture and data analysis on the lab experiemtents, specific for Aims 1… R01CA262577 $225,522
Duke University High-throughput functional annotation of gene regulatory elements and variants critical to UM1HG012053 $311,207
Duke University The duke center for combinatorial gene regulation: multigenic control of gene expression i RM1HG011123 $303,243
Dana-Farber Cancer Institute, Inc. Dr. Gimelbrant will oversee multi-deep sequencing, and related probe design for target capture and data analysis on the lab experiemtents, specific for Aims 1… R01CA262577 $148,995

Similar vendors

Vendor Location Primary NAICS
Fundacio Centre De Regulacio Genomica UEI RNNMMHPKCJR7 Barcelona, CT 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
I.r.c.m. UEI Y7DVWHJE2JB4 Montréal, QC —
Epigenome Technologies, Inc. UEI LS7JQN77JKQ1 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
WRI UEI N9LUQAMQPGZ8 Windber, PA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Sapere Bio ASN UEI Q3LKKRH87ES9 NC 621511 Medical Laboratories

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Altius Institute For Biomedical Sciences is a non-profit organization that provides research and analysis in the field of biomedical sciences to the federal government, focused on genetics, genomics, and aging research. Through prime federal grants from the National Institutes of Health (NIH), Altius Institute conducts research projects related to age-related gene expression and regulatory genomics. As a subawardee, Altius contributes expertise in areas such as multi-deep sequencing, phosphoproteomic profiling, and analyzing stem cells from blood donors with rare phenotypes to generate cultured red blood cells.

Specific federal grant programs Altius Institute has received funding under include research project grants from the National Institute on Aging to study causes of variegated gene expression related to aging and from the National Human Genome Research Institute to analyze principles regulating the genome. As a subawardee, Altius has provided sequencing and data analysis for genetics research led by Dana-Farber Cancer Institute and Mount Sinai, as well as supplying stem cell analysis for a project on proliferating cultured red blood cells for rare blood phenotypes led by Icahn School of Medicine.

Quick answers

Is Altius Institute For Biomedical Sciences registered in SAM.gov?

Yes. Altius Institute For Biomedical Sciences's SAM.gov registration is active through March 9, 2027.

Which contract vehicles does Altius Institute For Biomedical Sciences hold?

Altius Institute For Biomedical Sciences holds a place on 1 federal contract vehicle: CORE.

What is Altius Institute For Biomedical Sciences's most recent federal award?

Altius Institute For Biomedical Sciences's most recent federal grant award is Discriminating between causes of age-related variegated gene expression (R00AG061216), from National Institute on Aging (NIH), on February 1, 2022.

On GovTribe

See Altius Institute For Biomedical Sciences's full federal record

  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login